These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 35277417

  • 1. Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy.
    Zanchi C, Locatelli M, Cerullo D, Aumiller V, Corna D, Rottoli D, Eisermann M, Donadelli R, Mousavi M, Noris M, Remuzzi G, Benigni A, Zoja C.
    J Immunol; 2022 Apr 01; 208(7):1772-1781. PubMed ID: 35277417
    [Abstract] [Full Text] [Related]

  • 2. Liver factor B silencing to cure C3 glomerulopathy: Evidence from a mouse model of complement dysregulation.
    Zanchi C, Locatelli M, Corna D, Cerullo D, Fishilevich E, Desai D, Rottoli D, Donadelli R, Noris M, Zoja C, Remuzzi G, Benigni A.
    Mol Immunol; 2023 Sep 01; 161():25-32. PubMed ID: 37481826
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy.
    Zanchi C, Locatelli M, Cerullo D, Aumiller V, Corna D, Rottoli D, Schubert S, Noris M, Tomasoni S, Remuzzi G, Zoja C, Benigni A.
    Mol Immunol; 2024 Apr 01; 168():10-16. PubMed ID: 38368725
    [Abstract] [Full Text] [Related]

  • 4. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
    Noris M, Donadelli R, Remuzzi G.
    Pediatr Nephrol; 2019 Aug 01; 34(8):1311-1323. PubMed ID: 29948306
    [Abstract] [Full Text] [Related]

  • 5. Humanized C3 Mouse: A Novel Accelerated Model of C3 Glomerulopathy.
    Devalaraja-Narashimha K, Meagher K, Luo Y, Huang C, Kaplan T, Muthuswamy A, Halasz G, Casanova S, O'Brien J, Peyser Boiarsky R, McWhirter J, Gartner H, Bai Y, MacDonnell S, Liu C, Hu Y, Latuszek A, Wei Y, Prasad S, Huang T, Yancopoulos G, Murphy A, Olson W, Zambrowicz B, Macdonald L, Morton LG.
    J Am Soc Nephrol; 2021 Jan 01; 32(1):99-114. PubMed ID: 33288630
    [Abstract] [Full Text] [Related]

  • 6. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Osborne AJ, Breno M, Borsa NG, Bu F, Frémeaux-Bacchi V, Gale DP, van den Heuvel LP, Kavanagh D, Noris M, Pinto S, Rallapalli PM, Remuzzi G, Rodríguez de Cordoba S, Ruiz A, Smith RJH, Vieira-Martins P, Volokhina E, Wilson V, Goodship THJ, Perkins SJ.
    J Immunol; 2018 Apr 01; 200(7):2464-2478. PubMed ID: 29500241
    [Abstract] [Full Text] [Related]

  • 7. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
    Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V.
    Kidney Int; 2012 Aug 01; 82(4):454-64. PubMed ID: 22456601
    [Abstract] [Full Text] [Related]

  • 8. Defining the complement biomarker profile of C3 glomerulopathy.
    Zhang Y, Nester CM, Martin B, Skjoedt MO, Meyer NC, Shao D, Borsa N, Palarasah Y, Smith RJ.
    Clin J Am Soc Nephrol; 2014 Nov 07; 9(11):1876-82. PubMed ID: 25341722
    [Abstract] [Full Text] [Related]

  • 9. Dense deposit disease and C3 glomerulopathy.
    Barbour TD, Pickering MC, Terence Cook H.
    Semin Nephrol; 2013 Nov 07; 33(6):493-507. PubMed ID: 24161036
    [Abstract] [Full Text] [Related]

  • 10. An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.
    Yang Y, Denton H, Davies OR, Smith-Jackson K, Kerr H, Herbert AP, Barlow PN, Pickering MC, Marchbank KJ.
    J Am Soc Nephrol; 2018 Jun 07; 29(6):1649-1661. PubMed ID: 29588430
    [Abstract] [Full Text] [Related]

  • 11. Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily.
    Wang X, Van Lookeren Campagne M, Katschke KJ, Gullipalli D, Miwa T, Ueda Y, Wang Y, Palmer M, Xing G, Song WC.
    J Am Soc Nephrol; 2018 Aug 07; 29(8):2053-2059. PubMed ID: 29895552
    [Abstract] [Full Text] [Related]

  • 12. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.
    Iatropoulos P, Noris M, Mele C, Piras R, Valoti E, Bresin E, Curreri M, Mondo E, Zito A, Gamba S, Bettoni S, Murer L, Fremeaux-Bacchi V, Vivarelli M, Emma F, Daina E, Remuzzi G.
    Mol Immunol; 2016 Mar 07; 71():131-142. PubMed ID: 26895476
    [Abstract] [Full Text] [Related]

  • 13. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
    Donadelli R, Pulieri P, Piras R, Iatropoulos P, Valoti E, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2018 Mar 07; 9():2329. PubMed ID: 30487789
    [Abstract] [Full Text] [Related]

  • 14. von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.
    Chen YY, Han SS, Cao Y, Yu XJ, Zhu L, Luo JC, Song WC, Yu F, Mao YH, Zhao MH.
    Clin Immunol; 2021 Aug 07; 229():108794. PubMed ID: 34245915
    [Abstract] [Full Text] [Related]

  • 15. C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.
    Zhang Y, Meyer NC, Fervenza FC, Lau W, Keenan A, Cara-Fuentes G, Shao D, Akber A, Fremeaux-Bacchi V, Sethi S, Nester CM, Smith RJH.
    Am J Kidney Dis; 2017 Dec 07; 70(6):834-843. PubMed ID: 28838767
    [Abstract] [Full Text] [Related]

  • 16. C3 Glomerulopathy.
    Riedl M, Thorner P, Licht C.
    Pediatr Nephrol; 2017 Jan 07; 32(1):43-57. PubMed ID: 27056062
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort.
    Michels MAHM, Wijnsma KL, Kurvers RAJ, Westra D, Schreuder MF, van Wijk JAE, Bouts AHM, Gracchi V, Engels FAPT, Keijzer-Veen MG, Dorresteijn EM, Volokhina EB, van den Heuvel LPWJ, van de Kar NCAJ.
    Pediatr Nephrol; 2022 Mar 07; 37(3):601-612. PubMed ID: 34476601
    [Abstract] [Full Text] [Related]

  • 18. Complement activity is regulated in C3 glomerulopathy by IgG-factor H fusion proteins with and without properdin targeting domains.
    Gilmore AC, Zhang Y, Cook HT, Lavin DP, Katti S, Wang Y, Johnson KK, Kim S, Pickering MC.
    Kidney Int; 2021 Feb 07; 99(2):396-404. PubMed ID: 33129896
    [Abstract] [Full Text] [Related]

  • 19. C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice.
    Zhang Y, Keenan A, Dai DF, May KS, Anderson EE, Lindorfer MA, Henrich JB, Pitcher GR, Taylor RP, Smith RJ.
    JCI Insight; 2020 May 07; 5(9):. PubMed ID: 32376801
    [Abstract] [Full Text] [Related]

  • 20. Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.
    Sethi S, Fervenza FC, Zhang Y, Nasr SH, Leung N, Vrana J, Cramer C, Nester CM, Smith RJ.
    Clin J Am Soc Nephrol; 2011 May 07; 6(5):1009-17. PubMed ID: 21415311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.